Advertisement
Journal Home
Search for

Volume 38, Issue 2, Pages 141-153 (February 2010)


View previous. 9 of 11 View next.

Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease

Katia Todoertia, Gina Lisignolib, Paola Stortic, Luca Agnellia, Francesca Novarad, Cristina Manferdinib, Katia Codeluppib, Simona Collac, Monica Crugnolac, Manuela Abeltinoc, Marina Bolzonic, Valentina Sgobbac, Andrea Facchinib, Giorgio Lambertenghi-Deliliersa, Orsetta Zuffardid, Vittorio Rizzolic, Antonino Neria, Nicola GiulianicCorresponding Author Informationemail address

Received 18 August 2009; received in revised form 5 November 2009; accepted 24 November 2009. published online 07 December 2009.

Objective

Multiple myeloma (MM) is characterized by a high incidence of osteolytic bone lesions, which have been previously correlated with the gene expression profiles of MM cells. The aim of this study was to investigate the transcriptional patterns of cells in the bone microenvironment and their relationships with the presence of osteolysis in MM patients.

Materials and Methods

Both mesenchymal (MSC) and osteoblastic (OB) cells were isolated directly from bone biopsies of MM patients and controls to perform gene expression profiling by microarrays and real-time polymerase chain reaction on selected bone-related genes.

Results

We identified a series of upregulated and downregulated genes that were differentially expressed in the MSC cells of osteolytic and nonosteolytic patients. Comparison of the osteolytic and nonosteolytic samples also showed that the MSC cells and OB had distinct transcriptional patterns. No significantly modulated genes were found in the OBs of the osteolytic and nonosteolytic patients.

Conclusions

Our data suggest that the gene expression profiles of cells of the bone microenvironment are different in MM patients and controls, and that MSC cells, but not OBs, have a distinct transcriptional pattern associated with the occurrence of bone lesions in MM patients. These data support the idea that alterations in MSC cells may be involved in MM bone disease.

a Dipartimento di Scienze Mediche, Università di Milano e U.O. Ematologia 1, Fondazione IRCCS Policlinico, Milan, Italy

b Laboratorio di Immunologia e Genetica, Istituti Ortopedici Rizzoli, Bologna, Italy

c Ematologia e Centro Trapianti Midollo Osseo, Dipartimento di Medicina Interna e Scienze Biomediche, Azienda Ospedaliero-Universitaria, Parma, Italy

d Dipartimento di Patologia Umana ed Ereditaria, Sezione Biologia generale e Genetica Medica, University of Pavia, Pavia, Italy

Corresponding Author InformationOffprint requests to: Nicola Giuliani, M.D., Ph.D., Department of Internal Medicine and Biomedical Science, University of Parma, Via Gramsci 14, Parma 43100, Italy

PII: S0301-472X(09)00453-6

doi:10.1016/j.exphem.2009.11.009


View previous. 9 of 11 View next.